source
- ADARx raises $446 million in one of 2026's largest biotech IPOs as City Therapeutics plans its own listingADARx Pharmaceuticals completed an initial public offering that raised about $446.3 million, exceeding the company’s original target. The shares were priced at $17 each, with 26.25 million shares…
- Boston Scientific recalls Imager II angiographic catheters over tip detachment riskBoston Scientific has issued a recall of its Imager II Angiographic Catheters after a manufacturing problem that can cause the catheter tip to detach during use. The FDA classified the recall as t…